US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

1.49

-0.2600-14.86%

Volume:589.67K

Turnover:882.27K

Market Cap:5.32M

PE:-0.31

High:1.58

Open:1.49

Low:1.42

Close:1.75

52wk High:14.64

52wk Low:1.42

Shares:3.57M

Float Shares:3.22M

Volume Ratio:0.34

T/O Rate:18.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8667

EPS(LYR):-6.6394

ROE:-275.16%

ROA:-125.93%

PB:1.30

PE(LYR):-0.22

Loading ...

Overview Company News Filings

Cadrenal Therapeutics Wins FDA Alignment on Phase 3 CAD-1005 Trial Design in Heparin-Induced Thrombocytopenia

Cadrenal Therapeutics - Phase 3 Trial to Assess Bleeding as Major Safety Endpoint Using Isth Criteria

THOMSON REUTERS

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

THOMSON REUTERS

Cadrenal Therapeutics - FDA Agrees to Placebo Control with Standard Anticoagulation in CAD-1005 Phase 3 Trial

THOMSON REUTERS

Cadrenal Therapeutics - FDA Agrees on Optimized Primary Endpoint Definition for CAD-1005 Phase 3 Study

THOMSON REUTERS

Cadrenal Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Cadrenal Therapeutics Q2 EPS USD -1.14

THOMSON REUTERS

Cadrenal Therapeutics Q2 Net Loss Narrows 9.39% to $3.3 Million

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

THOMSON REUTERS

Cadrenal Therapeutics Inc Expected to Post a Loss of $1.42 a Share - Earnings Preview

Cadrenal Therapeutics Announces Annual Shareholder Meeting

Cadrenal Therapeutics Highlights Phase 2 Data for CAD-1005 in Heparin-Induced Thrombocytopenia, Eyes CSA-AKI Market

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

THOMSON REUTERS

Cadrenal Therapeutics - Expands CAD-1005 Development to Target Hit and Csa-Aki

THOMSON REUTERS

Cadrenal Aligns Pipeline into Cardiac Acute Critical Care Franchise, Shifts to Partnership-driven Model

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biogen (BIIB) and Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics files to sell 2.94M shares of common stock for holders

Cadrenal Says Phase 2 Trial of Cad-1005 Cuts Thrombotic Events by More than 25% in HIT

Cadrenal Rises as Blood Clot Drug Cuts Risk in Mid-stage Study

Cadrenal Therapeutics - Phase 2 Data Show over 25% Reduction in Thrombotic Events for Cad-1005

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CVKD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVKD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":1.49,"timestamp":1788278755177,"preClose":1.75,"halted":0,"volume":589668,"delay":0,"changeRate":-0.14857142857142858,"floatShares":3223023,"shares":3567600,"eps":-4.866724,"marketStatus":"Trading","change":-0.26,"latestTime":"09-01 12:06:24 EDT","open":1.49,"high":1.58,"low":1.42,"amount":882265.5072096,"amplitude":0.091429,"askPrice":1.49,"askSize":40,"bidPrice":1.48,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-4.866724,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":1.75,"preHourTrading":{"tag":"盘前","latestPrice":1.49,"preClose":1.75,"latestTime":"09:28 EDT","volume":111783,"amount":162545.6500374,"timestamp":1788269283019,"change":-0.26,"changeRate":-0.148571,"amplitude":0.119657},"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.75,"latestTime":"19:59 EDT","volume":485074,"amount":776785.9359,"timestamp":1788220799232,"change":-0.28,"changeRate":-0.16,"amplitude":0.188629},"volumeRatio":0.336845},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","floatShares":3223023,"roa":"-125.93%","roe":"-275.16%","lyrEps":-6.639405,"volumeRatio":0.336845,"shares":3567600,"dividePrice":0,"high":1.58,"amplitude":0.091429,"preClose":1.75,"low":1.42,"week52Low":1.42,"pbRate":"1.30","week52High":14.64,"institutionHeld":0,"latestPrice":1.49,"committee":-0.333333,"eps":-4.866724,"divideRate":0,"volume":589668,"delay":0,"ttmEps":-4.866724,"open":1.49,"prevYearClose":6.78,"prevWeekClose":1.54,"prevMonthClose":1.75,"prevQuarterClose":3.34,"fiveDayClose":1.53,"twentyDayClose":2.03,"sixtyDayClose":4.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVKD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"CVKD","fiscalQuarterEnding":"2026/06","expectedEps":-1.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2026-05-07","symbol":"CVKD","fiscalQuarterEnding":"2026/03","expectedEps":-1.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2026-03-31","symbol":"CVKD","fiscalQuarterEnding":"2025/12","expectedEps":-1.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-11-10","symbol":"CVKD","fiscalQuarterEnding":"2025/09","expectedEps":-1.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-08-11","symbol":"CVKD","fiscalQuarterEnding":"2025/06","expectedEps":-1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVKD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVKD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVKD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVKD","date":"2026-08-28","current":-0.359585,"percent":0.961009,"low":-6.5442,"twenty":-2.498975,"median":-1.454925,"eighty":-0.838248,"high":-0.407485,"avg":-1.765605,"sd":1.08517,"marketCap":5583281},"quantilePoints":[{"date":"2023-01-20","current":-6.5442,"twenty":-6.16384,"median":-5.593301,"eighty":-5.593301,"marketCap":47934449},{"date":"2023-01-27","current":-4.161603,"twenty":-5.973233,"median":-5.338088,"eighty":-4.549173,"marketCap":30482586},{"date":"2023-02-03","current":-3.812156,"twenty":-5.593301,"median":-4.511051,"eighty":-4.113951,"marketCap":27922980},{"date":"2023-02-10","current":-3.160912,"twenty":-5.38913,"median":-4.288675,"eighty":-3.488122,"marketCap":23152804},{"date":"2023-02-17","current":-3.573896,"twenty":-4.892266,"median":-4.082183,"eighty":-3.392818,"marketCap":26177793},{"date":"2023-02-24","current":-3.345166,"twenty":-4.587294,"median":-3.573896,"eighty":-3.380111,"marketCap":24502414},{"date":"2023-03-03","current":-2.875001,"twenty":-4.507652,"median":-3.569925,"eighty":-3.160912,"marketCap":21058580},{"date":"2023-03-10","current":-2.589089,"twenty":-4.478393,"median":-3.494476,"eighty":-3.058111,"marketCap":18964357},{"date":"2023-03-17","current":-2.271409,"twenty":-4.364918,"median":-3.399172,"eighty":-2.900415,"marketCap":16637442},{"date":"2023-03-24","current":-1.985498,"twenty":-4.145719,"median":-3.271465,"eighty":-2.525553,"marketCap":14543218},{"date":"2023-03-31","current":-2.239641,"twenty":-4.082183,"median":-3.15297,"eighty":-2.291105,"marketCap":16404750},{"date":"2023-04-06","current":-2.112569,"twenty":-4.082183,"median":-3.137086,"eighty":-2.249171,"marketCap":15473984},{"date":"2023-04-12","current":-2.229793,"twenty":-4.028178,"median":-3.11326,"eighty":-2.242818,"marketCap":16332616},{"date":"2023-04-21","current":-2.446133,"twenty":-3.866161,"median":-3.03114,"eighty":-2.237671,"marketCap":17917245},{"date":"2023-04-28","current":-2.366713,"twenty":-3.6692,"median":-2.946479,"eighty":-2.249171,"marketCap":17335516},{"date":"2023-05-05","current":-2.096686,"twenty":-3.573896,"median":-2.875001,"eighty":-2.188781,"marketCap":15357639},{"date":"2023-05-12","current":-1.444685,"twenty":-3.573896,"median":-2.612915,"eighty":-2.169752,"marketCap":17800899},{"date":"2023-05-19","current":-1.359704,"twenty":-3.569131,"median":-2.462017,"eighty":-2.077625,"marketCap":16753788},{"date":"2023-05-26","current":-1.284383,"twenty":-3.546035,"median":-2.446133,"eighty":-1.985498,"marketCap":15825717},{"date":"2023-06-02","current":-1.346224,"twenty":-3.517444,"median":-2.384186,"eighty":-1.928316,"marketCap":16587696},{"date":"2023-06-09","current":-1.503204,"twenty":-3.469062,"median":-2.334945,"eighty":-1.45944,"marketCap":18521951},{"date":"2023-06-16","current":-1.44612,"twenty":-3.43094,"median":-2.283322,"eighty":-1.45944,"marketCap":17818586},{"date":"2023-06-23","current":-1.484176,"twenty":-3.418233,"median":-2.263467,"eighty":-1.465148,"marketCap":18287496},{"date":"2023-06-30","current":-1.398551,"twenty":-3.367404,"median":-2.247583,"eighty":-1.465148,"marketCap":17232448},{"date":"2023-07-07","current":-1.417578,"twenty":-3.349614,"median":-2.226775,"eighty":-1.445833,"marketCap":17466903},{"date":"2023-07-14","current":-1.503299,"twenty":-3.286205,"median":-2.191989,"eighty":-1.443298,"marketCap":18523123},{"date":"2023-07-21","current":-1.637011,"twenty":-3.183023,"median":-2.150431,"eighty":-1.445833,"marketCap":20170670},{"date":"2023-07-28","current":-1.152922,"twenty":-3.160912,"median":-2.112569,"eighty":-1.436606,"marketCap":14205899},{"date":"2023-08-04","current":-1.14188,"twenty":-3.148205,"median":-2.045063,"eighty":-1.406161,"marketCap":14069843},{"date":"2023-08-11","current":-0.924489,"twenty":-3.132321,"median":-1.985498,"eighty":-1.379336,"marketCap":11854271},{"date":"2023-08-18","current":-0.791165,"twenty":-3.116437,"median":-1.961672,"eighty":-1.351057,"marketCap":10144725},{"date":"2023-08-25","current":-0.756633,"twenty":-3.058111,"median":-1.906237,"eighty":-1.33893,"marketCap":9701938},{"date":"2023-09-01","current":-0.782025,"twenty":-3.028503,"median":-1.714964,"eighty":-1.314525,"marketCap":10027520},{"date":"2023-09-08","current":-0.93325,"twenty":-2.992542,"median":-1.675857,"eighty":-1.277692,"marketCap":11966608},{"date":"2023-09-15","current":-0.791064,"twenty":-2.948067,"median":-1.596605,"eighty":-1.146297,"marketCap":10143423},{"date":"2023-09-22","current":-0.685541,"twenty":-2.919476,"median":-1.522232,"eighty":-1.104853,"marketCap":8790358},{"date":"2023-09-29","current":-0.680463,"twenty":-2.884531,"median":-1.503251,"eighty":-0.944749,"marketCap":8725245},{"date":"2023-10-06","current":-0.665229,"twenty":-2.792404,"median":-1.503204,"eighty":-0.904366,"marketCap":8529903},{"date":"2023-10-13","current":-0.649081,"twenty":-2.655802,"median":-1.479419,"eighty":-0.871399,"marketCap":8322842},{"date":"2023-10-20","current":-0.597183,"twenty":-2.61768,"median":-1.473616,"eighty":-0.791104,"marketCap":7657379},{"date":"2023-10-27","current":-0.503746,"twenty":-2.598619,"median":-1.465148,"eighty":-0.784463,"marketCap":6459285},{"date":"2023-11-03","current":-0.446871,"twenty":-2.525553,"median":-1.450877,"eighty":-0.769227,"marketCap":5730011},{"date":"2023-11-10","current":-0.446511,"twenty":-2.471547,"median":-1.444685,"eighty":-0.749525,"marketCap":5730011},{"date":"2023-11-17","current":-0.457674,"twenty":-2.462017,"median":-1.436606,"eighty":-0.722103,"marketCap":5873262},{"date":"2023-11-22","current":-0.507704,"twenty":-2.455663,"median":-1.417578,"eighty":-0.721088,"marketCap":6515283},{"date":"2023-12-01","current":-0.466807,"twenty":-2.446133,"median":-1.403307,"eighty":-0.699922,"marketCap":5990466},{"date":"2023-12-08","current":-0.471881,"twenty":-2.427072,"median":-1.388031,"eighty":-0.680463,"marketCap":6055580},{"date":"2023-12-15","current":-0.559052,"twenty":-2.387045,"median":-1.376708,"eighty":-0.648167,"marketCap":7174222},{"date":"2023-12-22","current":-0.56514,"twenty":-2.368619,"median":-1.351076,"eighty":-0.63015,"marketCap":7252358},{"date":"2023-12-29","current":-0.722638,"twenty":-2.366713,"median":-1.348603,"eighty":-0.629682,"marketCap":9273503},{"date":"2024-01-05","current":-0.635264,"twenty":-2.347652,"median":-1.341467,"eighty":-0.629743,"marketCap":8152244},{"date":"2024-01-12","current":-0.620651,"twenty":-2.315884,"median":-1.326907,"eighty":-0.629682,"marketCap":7964716},{"date":"2024-01-19","current":-0.953911,"twenty":-2.296823,"median":-1.312673,"eighty":-0.629723,"marketCap":12241388},{"date":"2024-01-26","current":-1.319238,"twenty":-2.284116,"median":-1.293897,"eighty":-0.63015,"marketCap":16929580},{"date":"2024-02-02","current":-1.430866,"twenty":-2.276174,"median":-1.320586,"eighty":-0.632524,"marketCap":18362083},{"date":"2024-02-09","current":-0.923467,"twenty":-2.265055,"median":-1.321934,"eighty":-0.637094,"marketCap":11850706},{"date":"2024-02-16","current":-0.791644,"twenty":-2.255525,"median":-1.298654,"eighty":-0.640854,"marketCap":10159050},{"date":"2024-02-23","current":-0.743847,"twenty":-2.252348,"median":-1.278807,"eighty":-0.643003,"marketCap":9545678},{"date":"2024-03-01","current":-0.714418,"twenty":-2.237671,"median":-1.221262,"eighty":-0.639426,"marketCap":9168018},{"date":"2024-03-08","current":-0.654241,"twenty":-2.228586,"median":-1.149822,"eighty":-0.640346,"marketCap":8395769},{"date":"2024-03-15","current":-1.139373,"twenty":-2.218452,"median":-1.14188,"eighty":-0.642618,"marketCap":9521837},{"date":"2024-03-22","current":-1.2068,"twenty":-2.196183,"median":-1.140626,"eighty":-0.643971,"marketCap":10085335},{"date":"2024-03-28","current":-1.225937,"twenty":-2.191989,"median":-1.148028,"eighty":-0.645513,"marketCap":10245260},{"date":"2024-04-05","current":-1.16485,"twenty":-2.176105,"median":-1.152922,"eighty":-0.647557,"marketCap":9734749},{"date":"2024-04-12","current":-0.835183,"twenty":-2.160222,"median":-1.146113,"eighty":-0.649081,"marketCap":6979692},{"date":"2024-04-19","current":-0.823306,"twenty":-2.140639,"median":-1.139373,"eighty":-0.654241,"marketCap":6880439},{"date":"2024-04-26","current":-0.81143,"twenty":-2.128453,"median":-1.124432,"eighty":-0.658604,"marketCap":6781187},{"date":"2024-05-03","current":-0.890734,"twenty":-2.112569,"median":-1.111003,"eighty":-0.664084,"marketCap":7443938},{"date":"2024-05-10","current":-0.929811,"twenty":-2.096686,"median":-1.0981,"eighty":-0.664287,"marketCap":7770510},{"date":"2024-05-17","current":-1.420575,"twenty":-2.049034,"median":-1.111003,"eighty":-0.665229,"marketCap":6885242},{"date":"2024-05-24","current":-1.383913,"twenty":-2.041092,"median":-1.124432,"eighty":-0.669767,"marketCap":6707548},{"date":"2024-05-31","current":-1.354187,"twenty":-2.034738,"median":-1.135559,"eighty":-0.672852,"marketCap":6563472},{"date":"2024-06-07","current":-1.651117,"twenty":-1.995028,"median":-1.145503,"eighty":-0.674597,"marketCap":8002633},{"date":"2024-06-14","current":-1.462522,"twenty":-1.985498,"median":-1.149334,"eighty":-0.676934,"marketCap":7088550},{"date":"2024-06-21","current":-1.516029,"twenty":-1.985498,"median":-1.156171,"eighty":-0.679183,"marketCap":7347887},{"date":"2024-06-28","current":-1.504138,"twenty":-1.985498,"median":-1.16485,"eighty":-0.680036,"marketCap":7290256},{"date":"2024-07-05","current":-1.592623,"twenty":-1.956907,"median":-1.185729,"eighty":-0.680463,"marketCap":7719123},{"date":"2024-07-12","current":-1.549057,"twenty":-1.928316,"median":-1.2068,"eighty":-0.68257,"marketCap":7507971},{"date":"2024-07-15","current":-1.520322,"twenty":-1.925139,"median":-1.2068,"eighty":-0.683272,"marketCap":7368698},{"date":"2024-08-02","current":-1.416942,"twenty":-1.921962,"median":-1.214031,"eighty":-0.683974,"marketCap":6867633},{"date":"2024-08-09","current":-1.111674,"twenty":-1.906237,"median":-1.225937,"eighty":-0.685541,"marketCap":6933267},{"date":"2024-08-16","current":-1.293659,"twenty":-1.846933,"median":-1.234183,"eighty":-0.690721,"marketCap":8068268},{"date":"2024-08-23","current":-1.172164,"twenty":-1.818901,"median":-1.225937,"eighty":-0.699354,"marketCap":7310532},{"date":"2024-08-30","current":-1.264569,"twenty":-1.714964,"median":-1.241521,"eighty":-0.700775,"marketCap":7886837},{"date":"2024-09-06","current":-1.377507,"twenty":-1.706882,"median":-1.245795,"eighty":-0.702272,"marketCap":8591209},{"date":"2024-09-13","current":-1.830972,"twenty":-1.706882,"median":-1.246644,"eighty":-0.711712,"marketCap":11419371},{"date":"2024-09-20","current":-1.918243,"twenty":-1.834164,"median":-1.261146,"eighty":-0.71433,"marketCap":11963659},{"date":"2024-09-27","current":-2.482935,"twenty":-1.908638,"median":-1.273231,"eighty":-0.715692,"marketCap":15485521},{"date":"2024-10-04","current":-1.950755,"twenty":-1.957258,"median":-1.289021,"eighty":-0.720072,"marketCap":12166433},{"date":"2024-10-11","current":-1.928578,"twenty":-1.985498,"median":-1.30307,"eighty":-0.721088,"marketCap":12028120},{"date":"2024-10-18","current":-2.789238,"twenty":-2.037954,"median":-1.318426,"eighty":-0.721575,"marketCap":17395865},{"date":"2024-10-25","current":-2.86453,"twenty":-2.049228,"median":-1.322439,"eighty":-0.722103,"marketCap":17865446},{"date":"2024-10-31","current":-3.933452,"twenty":-2.070731,"median":-1.331376,"eighty":-0.722465,"marketCap":24532076},{"date":"2024-11-08","current":-3.909452,"twenty":-2.133327,"median":-1.338437,"eighty":-0.727802,"marketCap":24382399},{"date":"2024-11-15","current":-3.259855,"twenty":-2.194086,"median":-1.341467,"eighty":-0.734352,"marketCap":24801495},{"date":"2024-11-22","current":-3.282348,"twenty":-2.233732,"median":-1.351028,"eighty":-0.73941,"marketCap":24972628},{"date":"2024-11-29","current":-3.558806,"twenty":-2.265055,"median":-1.353013,"eighty":-0.74173,"marketCap":27075962},{"date":"2024-12-06","current":-3.132405,"twenty":-2.307334,"median":-1.357489,"eighty":-0.742873,"marketCap":23831837},{"date":"2024-12-13","current":-2.717719,"twenty":-2.368619,"median":-1.360113,"eighty":-0.745058,"marketCap":20676837},{"date":"2024-12-20","current":-3.394806,"twenty":-2.438951,"median":-1.363105,"eighty":-0.747693,"marketCap":25828222},{"date":"2024-12-27","current":-3.854006,"twenty":-2.462017,"median":-1.369978,"eighty":-0.749448,"marketCap":29321894},{"date":"2025-01-03","current":-3.631435,"twenty":-2.481224,"median":-1.377507,"eighty":-0.751556,"marketCap":27628533},{"date":"2025-01-10","current":-3.877435,"twenty":-2.523165,"median":-1.379523,"eighty":-0.753182,"marketCap":29500143},{"date":"2025-01-17","current":-4.264007,"twenty":-2.624538,"median":-1.387215,"eighty":-0.756024,"marketCap":32441245},{"date":"2025-01-24","current":-4.636522,"twenty":-2.674136,"median":-1.387903,"eighty":-0.758704,"marketCap":35275397},{"date":"2025-01-31","current":-4.458465,"twenty":-2.840559,"median":-1.398551,"eighty":-0.76167,"marketCap":33920708},{"date":"2025-02-07","current":-4.474865,"twenty":-2.909946,"median":-1.409317,"eighty":-0.766663,"marketCap":34045482},{"date":"2025-02-14","current":-4.49595,"twenty":-2.953876,"median":-1.417578,"eighty":-0.770226,"marketCap":34205906},{"date":"2025-02-21","current":-4.50415,"twenty":-3.001398,"median":-1.420575,"eighty":-0.772831,"marketCap":34268293},{"date":"2025-02-28","current":-4.313207,"twenty":-3.066784,"median":-1.427287,"eighty":-0.777478,"marketCap":32815567},{"date":"2025-03-07","current":-3.912578,"twenty":-3.139979,"median":-1.436606,"eighty":-0.780079,"marketCap":29767516},{"date":"2025-03-14","current":-4.088293,"twenty":-3.197171,"median":-1.445403,"eighty":-0.780934,"marketCap":31104380},{"date":"2025-03-21","current":-3.441281,"twenty":-3.248668,"median":-1.453604,"eighty":-0.782025,"marketCap":36654345},{"date":"2025-03-28","current":-3.301865,"twenty":-3.277995,"median":-1.456931,"eighty":-0.78237,"marketCap":35169374},{"date":"2025-04-04","current":-2.968325,"twenty":-3.266821,"median":-1.464503,"eighty":-0.783762,"marketCap":31616722},{"date":"2025-04-11","current":-2.518311,"twenty":-3.259068,"median":-1.469382,"eighty":-0.787263,"marketCap":26823461},{"date":"2025-04-17","current":-2.85891,"twenty":-3.257859,"median":-1.474662,"eighty":-0.790653,"marketCap":30451302},{"date":"2025-04-25","current":-3.000091,"twenty":-3.257392,"median":-1.49369,"eighty":-0.791084,"marketCap":31955070},{"date":"2025-05-02","current":-2.911853,"twenty":-3.251752,"median":-1.503204,"eighty":-0.791261,"marketCap":31015215},{"date":"2025-05-09","current":-2.270277,"twenty":-3.230283,"median":-1.504138,"eighty":-0.792361,"marketCap":29135505},{"date":"2025-05-16","current":-2.217562,"twenty":-3.211785,"median":-1.51768,"eighty":-0.795364,"marketCap":28458997},{"date":"2025-05-23","current":-2.303286,"twenty":-3.207473,"median":-1.520322,"eighty":-0.798283,"marketCap":29559125},{"date":"2025-05-30","current":-2.048131,"twenty":-3.194675,"median":-1.522232,"eighty":-0.80779,"marketCap":26284611},{"date":"2025-06-06","current":-2.238922,"twenty":-3.17692,"median":-1.535185,"eighty":-0.81143,"marketCap":28733121},{"date":"2025-06-13","current":-2.297156,"twenty":-3.160912,"median":-1.541956,"eighty":-0.811839,"marketCap":29480458},{"date":"2025-06-20","current":-2.051962,"twenty":-3.160912,"median":-1.546017,"eighty":-0.812362,"marketCap":26333778},{"date":"2025-06-27","current":-1.575368,"twenty":-3.148205,"median":-1.553351,"eighty":-0.816087,"marketCap":20217419},{"date":"2025-07-03","current":-1.989132,"twenty":-3.137454,"median":-1.556427,"eighty":-0.819168,"marketCap":25527441},{"date":"2025-07-11","current":-1.992197,"twenty":-3.130448,"median":-1.575368,"eighty":-0.822233,"marketCap":25566775},{"date":"2025-07-18","current":-1.819029,"twenty":-3.122655,"median":-1.585907,"eighty":-0.824111,"marketCap":23344432},{"date":"2025-07-25","current":-1.748536,"twenty":-3.115288,"median":-1.592623,"eighty":-0.830969,"marketCap":22439761},{"date":"2025-08-01","current":-1.596822,"twenty":-3.112066,"median":-1.60755,"eighty":-0.83978,"marketCap":20492753},{"date":"2025-08-08","current":-1.687442,"twenty":-3.09327,"median":-1.615212,"eighty":-0.845488,"marketCap":21655715},{"date":"2025-08-15","current":-1.874525,"twenty":-3.081005,"median":-1.616467,"eighty":-0.850297,"marketCap":26445353},{"date":"2025-08-22","current":-1.806334,"twenty":-3.070504,"median":-1.637011,"eighty":-0.858896,"marketCap":25483332},{"date":"2025-08-29","current":-1.928207,"twenty":-3.05288,"median":-1.651282,"eighty":-0.863774,"marketCap":27202689},{"date":"2025-09-05","current":-1.815039,"twenty":-3.045161,"median":-1.654092,"eighty":-0.866712,"marketCap":25606143},{"date":"2025-09-12","current":-1.958675,"twenty":-3.041134,"median":-1.665783,"eighty":-0.875806,"marketCap":27632529},{"date":"2025-09-19","current":-1.935461,"twenty":-3.028991,"median":-1.685629,"eighty":-0.883586,"marketCap":27305032},{"date":"2025-09-26","current":-2.060236,"twenty":-3.01081,"median":-1.701972,"eighty":-0.884716,"marketCap":29065326},{"date":"2025-10-03","current":-2.058785,"twenty":-2.99162,"median":-1.71336,"eighty":-0.887838,"marketCap":29044858},{"date":"2025-10-10","current":-2.058785,"twenty":-2.977972,"median":-1.730146,"eighty":-0.89028,"marketCap":29044858},{"date":"2025-10-17","current":-2.005828,"twenty":-2.973266,"median":-1.744222,"eighty":-0.89604,"marketCap":28297756},{"date":"2025-10-24","current":-1.997849,"twenty":-2.966913,"median":-1.748536,"eighty":-0.904366,"marketCap":28185179},{"date":"2025-10-31","current":-1.874525,"twenty":-2.963428,"median":-1.767691,"eighty":-0.910735,"marketCap":26445353},{"date":"2025-11-07","current":-1.770062,"twenty":-2.961332,"median":-1.774587,"eighty":-0.921067,"marketCap":24971618},{"date":"2025-11-14","current":-1.657615,"twenty":-2.959148,"median":-1.761439,"eighty":-0.923876,"marketCap":23845849},{"date":"2025-11-21","current":-1.630588,"twenty":-2.955352,"median":-1.753133,"eighty":-0.926618,"marketCap":23457048},{"date":"2025-11-28","current":-1.354629,"twenty":-2.954378,"median":-1.747124,"eighty":-0.930499,"marketCap":19487202},{"date":"2025-12-05","current":-1.601728,"twenty":-2.954068,"median":-1.744222,"eighty":-0.934516,"marketCap":23041879},{"date":"2025-12-12","current":-1.587298,"twenty":-2.950868,"median":-1.73848,"eighty":-0.939656,"marketCap":22834295},{"date":"2025-12-19","current":-1.063489,"twenty":-2.940291,"median":-1.726315,"eighty":-0.940873,"marketCap":15298977},{"date":"2025-12-26","current":-1.063489,"twenty":-2.940291,"median":-1.71823,"eighty":-0.944523,"marketCap":15298977},{"date":"2026-01-02","current":-1.101967,"twenty":-2.938888,"median":-1.708991,"eighty":-0.944976,"marketCap":15852501},{"date":"2026-01-09","current":-1.280752,"twenty":-2.91719,"median":-1.701972,"eighty":-0.952147,"marketCap":18424440},{"date":"2026-01-16","current":-1.332762,"twenty":-2.904794,"median":-1.687875,"eighty":-0.957005,"marketCap":19172641},{"date":"2026-01-23","current":-1.241744,"twenty":-2.899853,"median":-1.679836,"eighty":-0.969272,"marketCap":17863290},{"date":"2026-01-30","current":-1.212489,"twenty":-2.893625,"median":-1.665783,"eighty":-0.98096,"marketCap":17442427},{"date":"2026-02-06","current":-0.867921,"twenty":-2.886524,"median":-1.656007,"eighty":-0.98096,"marketCap":12485598},{"date":"2026-02-13","current":-0.880923,"twenty":-2.881499,"median":-1.651447,"eighty":-0.944863,"marketCap":12672648},{"date":"2026-02-20","current":-1.009324,"twenty":-2.878053,"median":-1.641539,"eighty":-0.941701,"marketCap":14519768},{"date":"2026-02-27","current":-1.362018,"twenty":-2.873859,"median":-1.62773,"eighty":-0.944396,"marketCap":19593504},{"date":"2026-03-06","current":-1.299443,"twenty":-2.8691,"median":-1.617721,"eighty":-0.944749,"marketCap":18693325},{"date":"2026-03-13","current":-1.16698,"twenty":-2.862282,"median":-1.60245,"eighty":-0.948618,"marketCap":16787751},{"date":"2026-03-20","current":-1.132848,"twenty":-2.857498,"median":-1.596822,"eighty":-0.955458,"marketCap":16296745},{"date":"2026-03-27","current":-0.851668,"twenty":-2.854674,"median":-1.589961,"eighty":-0.944749,"marketCap":12251785},{"date":"2026-04-02","current":-0.865491,"twenty":-2.853417,"median":-1.587275,"eighty":-0.939656,"marketCap":11456822},{"date":"2026-04-10","current":-0.941191,"twenty":-2.848599,"median":-1.585719,"eighty":-0.93011,"marketCap":12458880},{"date":"2026-04-17","current":-0.918466,"twenty":-2.823863,"median":-1.582965,"eighty":-0.926432,"marketCap":12158062},{"date":"2026-04-24","current":-1.04724,"twenty":-2.784819,"median":-1.573829,"eighty":-0.927082,"marketCap":13862698},{"date":"2026-05-01","current":-1.551057,"twenty":-2.759024,"median":-1.555271,"eighty":-0.929709,"marketCap":20531907},{"date":"2026-05-08","current":-1.399905,"twenty":-2.724786,"median":-1.551057,"eighty":-0.93011,"marketCap":18531046},{"date":"2026-05-15","current":-1.36454,"twenty":-2.71069,"median":-1.547537,"eighty":-0.931696,"marketCap":16222361},{"date":"2026-05-22","current":-1.338647,"twenty":-2.679763,"median":-1.541956,"eighty":-0.934516,"marketCap":15914536},{"date":"2026-05-29","current":-1.29463,"twenty":-2.668509,"median":-1.537105,"eighty":-0.93958,"marketCap":15391235},{"date":"2026-06-05","current":-1.115971,"twenty":-2.647139,"median":-1.531678,"eighty":-0.939961,"marketCap":13267244},{"date":"2026-06-12","current":-1.043472,"twenty":-2.647139,"median":-1.522232,"eighty":-0.941191,"marketCap":12405335},{"date":"2026-06-18","current":-0.747912,"twenty":-2.638821,"median":-1.519662,"eighty":-0.938314,"marketCap":8891565},{"date":"2026-06-26","current":-0.690009,"twenty":-2.628688,"median":-1.514039,"eighty":-0.929033,"marketCap":8203186},{"date":"2026-07-02","current":-0.7648,"twenty":-2.625072,"median":-1.503718,"eighty":-0.92408,"marketCap":9092342},{"date":"2026-07-10","current":-0.726198,"twenty":-2.614313,"median":-1.503204,"eighty":-0.915436,"marketCap":8633423},{"date":"2026-07-17","current":-0.56214,"twenty":-2.59754,"median":-1.488933,"eighty":-0.902969,"marketCap":6683015},{"date":"2026-07-24","current":-0.489762,"twenty":-2.58972,"median":-1.474662,"eighty":-0.890464,"marketCap":5822541},{"date":"2026-07-31","current":-0.504237,"twenty":-2.586191,"median":-1.473616,"eighty":-0.884716,"marketCap":5994636},{"date":"2026-08-07","current":-0.45116,"twenty":-2.579965,"median":-1.46932,"eighty":-0.880724,"marketCap":5363621},{"date":"2026-08-14","current":-0.448747,"twenty":-2.553613,"median":-1.465148,"eighty":-0.866463,"marketCap":5334939},{"date":"2026-08-21","current":-0.491387,"twenty":-2.514854,"median":-1.460375,"eighty":-0.851932,"marketCap":5672471},{"date":"2026-08-28","current":-0.483661,"twenty":-2.498975,"median":-1.454925,"eighty":-0.838248,"marketCap":5583281}],"updateTime":1788247011599},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVKD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663200815","title":"Cadrenal Therapeutics Wins FDA Alignment on Phase 3 CAD-1005 Trial Design in Heparin-Induced Thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2663200815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663200815?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:05","pubTimestamp":1788177934,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics wins FDA alignment on Phase 3 CAD-1005 trial design in heparin-induced thrombocytopeniaCadrenal Therapeutics reported a positive FDA Type D meeting supporting its Phase 3 registr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9589jj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","CVKD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","LU0314104364.USD","BCDF","BK4585","BK4007","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","BK4588","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663086100","title":"Cadrenal Therapeutics - Phase 3 Trial to Assess Bleeding as Major Safety Endpoint Using Isth Criteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2663086100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663086100?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA9V40N6:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663085460","title":"Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2663085460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663085460?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA9V40N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663085250","title":"Cadrenal Therapeutics - FDA Agrees to Placebo Control with Standard Anticoagulation in CAD-1005 Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663085250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663085250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA9V40N6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008545","title":"Cadrenal Therapeutics - FDA Agrees on Optimized Primary Endpoint Definition for CAD-1005 Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008545?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA9V40N6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659122639","title":"Cadrenal Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659122639","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659122639?lang=en_us&edition=fundamental","pubTime":"2026-08-15 07:05","pubTimestamp":1786748722,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCadrenal Therapeutics IncCVKD.OQreported a quarterly adjusted loss of $1.14 per share for the quarter ended Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160647","title":"Cadrenal Therapeutics Q2 EPS USD -1.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160647?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:51","pubTimestamp":1786654293,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXLVTSNN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716799","title":"Cadrenal Therapeutics Q2 Net Loss Narrows 9.39% to $3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716799","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659716799?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:24","pubTimestamp":1786652694,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Q2 net loss narrows 9.39% to $3.3 millionCadrenal posted a Q2 net loss of USD 3.32 million, narrowing from USD 3.67 million a year earlier.Operating loss narrowed to USD 3.34 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8dRyJ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","CVKD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","BK4007","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","BCDF","IE00BN0W2W23.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816270","title":"Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816270?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA5GGTS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657647570","title":"Cadrenal Therapeutics Inc Expected to Post a Loss of $1.42 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657647570","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657647570?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:43","pubTimestamp":1786117385,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc <CVKD.OQ> expected to post a loss of $1.42 a share - Earnings PreviewCadrenal Therapeutics IncCVKD.OQCVKD.Ois expected to  show no change in quarterly revenue when it reports","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656020723","title":"Cadrenal Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656020723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656020723?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:10","pubTimestamp":1785791425,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics announces annual shareholder meetingCadrenal Therapeutics will hold its annual shareholder meeting virtually on Sept. 24, 2026.Shareholders will vote on the election of a Class I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL7yxQMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656437915","title":"Cadrenal Therapeutics Highlights Phase 2 Data for CAD-1005 in Heparin-Induced Thrombocytopenia, Eyes CSA-AKI Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2656437915","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656437915?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:32","pubTimestamp":1785760326,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics highlights Phase 2 data for CAD-1005 in heparin-induced thrombocytopenia, eyes CSA-AKI marketCadrenal Therapeutics sharpened its development plan for CAD-1005, targeting both hep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL7BWzHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656954379","title":"Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656954379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656954379?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:30","pubTimestamp":1785760209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737993","title":"Cadrenal Therapeutics - Expands CAD-1005 Development to Target Hit and Csa-Aki","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656737993?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:30","pubTimestamp":1785760209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400QA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272795","title":"Cadrenal Aligns Pipeline into Cardiac Acute Critical Care Franchise, Shifts to Partnership-driven Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272795","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653272795?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:06","pubTimestamp":1784635584,"startTime":"0","endTime":"0","summary":"Cadrenal aligns pipeline into Cardiac Acute Critical Care Franchise, shifts to partnership-driven modelCadrenal reorganized its clinical portfolio into a Cardiac Acute Critical Care Franchise, shiftin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL1m3yfP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","LU0314104364.USD","LU2095319765.USD","BCDF","BK4585","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","BK4007","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140106","title":"Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biogen (BIIB) and Cadrenal Therapeutics, Inc. (CVKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140106?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:01","pubTimestamp":1784034072,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Madrigal Pharmaceuticals (MDGL), Biogen (BIIB) and C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-madrigal-pharmaceuticals-mdgl-biogen-biib-and-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-madrigal-pharmaceuticals-mdgl-biogen-biib-and-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PBE","BK4137","BK4581","BMED","LU0109394709.USD","LABU","LU0029874061.USD","LU0889565916.HKD","BIIB","BK4588","LU0128526141.USD","BK4532","HCSG","XBI","XLV","IE00B19Z9P08.USD","LU0320765992.SGD","BK4007","BK4533","LU0234570918.USD","IE00B894F039.SGD","MDGL","IE00B19Z9Z06.USD","CVKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651142590","title":"Cadrenal Therapeutics files to sell 2.94M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2651142590","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651142590?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:15","pubTimestamp":1783977307,"startTime":"0","endTime":"0","summary":"17:12 EDT Cadrenal Therapeutics (CVKD) files to sell 2.94M shares of common stock for holders Published first on TheFly – the ultimate source for r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-files-to-sell-2-94m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-files-to-sell-2-94m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CVKD","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114023","title":"Cadrenal Says Phase 2 Trial of Cad-1005 Cuts Thrombotic Events by More than 25% in HIT","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114023","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114023?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:24","pubTimestamp":1783949083,"startTime":"0","endTime":"0","summary":"Cadrenal says Phase 2 trial of CAD-1005 cuts thrombotic events by more than 25% in HITCadrenal reported Phase 2 data for CAD-1005 in HIT showing an absolute reduction of more than 25% in thrombotic ev","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDLFJpC3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","BK4588","NDAQ","BK4112","LU2095319765.USD","LU2210149790.SGD","BK4585","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4007","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","CVKD","IE00BGHQF748.EUR","SG9999014005.SGD","BCDF","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651611443","title":"Cadrenal Rises as Blood Clot Drug Cuts Risk in Mid-stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651611443","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651611443?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:11","pubTimestamp":1783948269,"startTime":"0","endTime":"0","summary":"BUZZ-Cadrenal rises as blood clot drug cuts risk in mid-stage study** Shares of Cadrenal TherapeuticsCVKD.Orise 7.6% to $3.11 premarket** Co says its experimental drug CAD-1005 cut new or worsening bl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4N43F13R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651517114","title":"Cadrenal Therapeutics - Phase 2 Data Show over 25% Reduction in Thrombotic Events for Cad-1005","url":"https://stock-news.laohu8.com/highlight/detail?id=2651517114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651517114?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:01","pubTimestamp":1783947663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":79,"code":"91000000","status":"200"}]}}